|3/ADec 13, 4:00 PM ET

KOS PHARMACEUTICALS INC 3/A

3/A · KOS PHARMACEUTICALS INC · Filed Dec 13, 2006

Insider Transaction Report

Form 3/AAmended
Period: 2004-07-29
Ferro Kevin
Director
Holdings
  • Common Stock, $.01 par value

    270

Documents

1 file
  • 3
    primary_doc.xml

    PRIMARY DOCUMENT